You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Havrix safety

For further information on Havrix including possible side effects and who should not be given Havrix, please see:

Havrix Monodose Patient Information Leaflet (PIL)

Havrix Junior Monodose Patient Information Leaflet (PIL)

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at http://mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

Havrix is a registered trademark of the GlaxoSmithKline Group of Companies